Barlan Kari, Bhide Gaurang P, White Derek R, Lake Marc R, Lu Charles, Rieder Stephanie E, Fan Lianchun, Hsieh Chen-Lin
Genomics Research Center, North Chicago, IL, United States.
Biologics Analytical Research and Development, Worcester, MA, United States.
SLAS Discov. 2024 Jan;29(1):52-58. doi: 10.1016/j.slasd.2023.10.004. Epub 2023 Oct 14.
N-linked glycosylation is a common post-translational modification that has various effects on multiple types of proteins. The extent to which an N-linked glycoprotein is modified and the identity of glycans species involved is of great interest to the biopharmaceutical industry, since glycosylation can impact the efficacy and safety of therapeutic monoclonal antibodies (mAbs). mAbs lacking core fucose, for example, display enhanced clinical efficacy through increased antibody-dependent cellular cytotoxicity. We performed a genome-wide CRISPR knockout screen in Chinese hamster ovary (CHO) cells, the workhorse cell culture system for industrial production of mAbs, aimed at identifying novel regulators of protein fucosylation. Using a lectin binding assay, we identified 224 gene perturbations that significantly alter protein fucosylation, including well-known glycosylation genes. This functional genomics framework could readily be extended and applied to study the genetic pathways involved in regulation of other glycoforms. We hope this resource will provide useful guidance toward the development of next generation CHO cell lines and mAb therapeutics.
N-糖基化是一种常见的翻译后修饰,对多种类型的蛋白质具有多种影响。N-连接糖蛋白的修饰程度以及所涉及的聚糖种类的身份,是生物制药行业非常感兴趣的,因为糖基化会影响治疗性单克隆抗体(mAb)的疗效和安全性。例如,缺乏核心岩藻糖的单克隆抗体通过增加抗体依赖性细胞毒性表现出增强的临床疗效。我们在中国仓鼠卵巢(CHO)细胞中进行了全基因组CRISPR敲除筛选,CHO细胞是用于工业生产单克隆抗体的主要细胞培养系统,旨在鉴定蛋白质岩藻糖基化的新型调节因子。使用凝集素结合试验,我们鉴定出224个显著改变蛋白质岩藻糖基化的基因扰动,包括众所周知的糖基化基因。这种功能基因组学框架可以很容易地扩展并应用于研究参与其他糖型调控的遗传途径。我们希望这个资源将为下一代CHO细胞系和单克隆抗体治疗药物的开发提供有用的指导。